The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Medical oncologists’ perceptions of clinical trials for underrepresented populations.
 
Giselle Katiria Perez
No Relationships to Disclose
 
Elyse R. Park
Honoraria - UpToDate
Research Funding - Pfizer
 
Nora K. Horick
No Relationships to Disclose
 
Helen Mizrach
No Relationships to Disclose
 
Ryan David Nipp
No Relationships to Disclose
 
Sydney Crute
No Relationships to Disclose
 
Bruce Allan Chabner
Stock and Other Ownership Interests - Alnylam; Biomarin; Blueprint Medicines; Blueprint Medicines; Celgene; Constellation Pharmaceuticals; Epizyme; GlaxoSmithKline; Loxo; PharmaMar; Seagen; SpringWorks Therapeutics
Honoraria - Bristol-Myers Squibb; Bristol-Myers Squibb
Consulting or Advisory Role - Chugai Pharma; cyteir; EMD Serono; PharmaMar
Expert Testimony - Lilly
Travel, Accommodations, Expenses - PharmaMar
 
Beverly Moy
Consulting or Advisory Role - Dark Canyon Labs (I); MOTUS (I); Remedy Partners (I)
Research Funding - Puma Biotechnology (Inst)